Tyche Wealth Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Sell |
209,868
-55,898
| -21% | -$40.9K | 0.03% | 286 |
|
|
2025
Q1 | $214K | Sell |
265,766
-1,000
| -0.4% | -$807 | 0.05% | 263 |
|
|
2024
Q4 | $368K | Buy |
266,766
+50,864
| +24% | +$70.2K | 0.08% | 184 |
|
|
2024
Q3 | $225K | Hold |
215,902
| – | – | 0.05% | 254 |
|
|
2024
Q2 | $374K | Hold |
215,902
| – | – | 0.09% | 161 |
|
|
2024
Q1 | $516K | Hold |
215,902
| – | – | 0.13% | 133 |
|
|
2023
Q4 | $719K | Buy |
+215,902
| New | +$719K | 0.17% | 112 |
|